Cargando…

STAT3 and its targeting inhibitors in osteosarcoma

Signal transducer and activator of transcription 3 (STAT3) is one of seven STAT family members involved with the regulation of cellular growth, differentiation and survival. STAT proteins are conserved among eukaryotes and are important for biological functions of embryogenesis, immunity, haematopoi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yun, Liao, Shijie, Bennett, Samuel, Tang, Haijun, Song, Dezhi, Wood, David, Zhan, Xinli, Xu, Jiake
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848963/ https://www.ncbi.nlm.nih.gov/pubmed/33382511 http://dx.doi.org/10.1111/cpr.12974

Ejemplares similares

Current research progress in targeted anti‐angiogenesis therapy for osteosarcoma
por: Liu, Yun, et al.
Publicado: (2021)

Single-Cell Transcriptome Analysis Reveals Paraspeckles Expression in Osteosarcoma Tissues
por: Rothzerg, Emel, et al.
Publicado: (2022)

A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes
por: Tang, Haijun, et al.
Publicado: (2023)

Interaction gene set between osteoclasts and regulatory CD4(+) T cells can accurately predict the prognosis of patients with osteosarcoma
por: Li, Feicui, et al.
Publicado: (2023)

Sodium cantharidate targets STAT3 and abrogates EGFR inhibitor resistance in osteosarcoma
por: Ji, Xiang Lu, et al.
Publicado: (2019)

RNA-seq and Single-Cell Transcriptome Analyses of TRAIL Receptors Gene Expression in Human Osteosarcoma Cells and Tissues
por: Feng, Wenyu, et al.
Publicado: (2023)

Identification of Differentially Expressed Intronic Transcripts in Osteosarcoma
por: Rothzerg, Emel, et al.
Publicado: (2022)

Long non-coding RNA and circular RNA and coding RNA profiling of plasma exosomes of osteosarcoma by RNA seq
por: Liu, Yun, et al.
Publicado: (2023)

ATG16L1 is a Potential Prognostic Biomarker and Immune Signature for Osteosarcoma: A Study Based on Bulk RNA and Single-Cell RNA-Sequencing
por: Qin, Zhaojie, et al.
Publicado: (2022)

Single-Cell Transcriptomics Reveals the Complexity of the Tumor Microenvironment of Treatment-Naive Osteosarcoma
por: Liu, Yun, et al.
Publicado: (2021)

Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma
por: Yu, Peter Y., et al.
Publicado: (2017)

Corrigendum: Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma
por: Liu, Yun, et al.
Publicado: (2022)

Intraperitoneal extraosseous osteosarcoma: a case report and literatures review
por: Wang, Tiantian, et al.
Publicado: (2020)

Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3
por: Zhang, T, et al.
Publicado: (2017)

STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma
por: Oi, Toru, et al.
Publicado: (2016)

Correction: Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3
por: Zhang, T., et al.
Publicado: (2019)

Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma
por: Rothzerg, Emel, et al.
Publicado: (2021)

Significance of the neutrophil-to-lymphocyte ratio in predicting the response to neoadjuvant chemotherapy in extremity osteosarcoma: a multicentre retrospective study
por: Tang, Haijun, et al.
Publicado: (2022)

Isoliensinine Suppresses Osteoclast Formation Through NF-κB Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss
por: Liu, Huijiang, et al.
Publicado: (2022)

Long Noncoding RNA MALAT1 Interacts with miR-124-3p to Modulate Osteosarcoma Progression by Targeting SphK1
por: Liu, Bin, et al.
Publicado: (2021)

Characterization of STAT3 activation and expression in canine and human osteosarcoma
por: Fossey, Stacey L, et al.
Publicado: (2009)

STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma
por: Jiang, Mingjing, et al.
Publicado: (2022)

Tanshinone I inhibits the growth and metastasis of osteosarcoma via suppressing JAK/STAT3 signalling pathway
por: Wang, Weiguo, et al.
Publicado: (2019)

Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1–3, suppresses osteosarcoma proliferation and invasion via dual role in tumor cells and tumor microenvironment
por: Liao, Song, et al.
Publicado: (2023)

Novel STAT3 Inhibitors Targeting STAT3 Dimerization by Binding to the STAT3 SH2 Domain
por: Hua, Yaping, et al.
Publicado: (2022)

Diagnosis and treatment of primary hyperparathyroidism with pathological fracture of the limbs: A retrospective observational study
por: Liu, Huijiang, et al.
Publicado: (2022)

Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines
por: Couto, Jason I, et al.
Publicado: (2012)

Characterizing the metabolic role of STAT3 in canine osteosarcoma
por: Gardner, Heather L., et al.
Publicado: (2022)

Molecular Structure, Expression and Role of TAFA4 and its Receptor FPR1 in the Spinal Cord
por: Zhu, Sipin, et al.
Publicado: (2022)

Protein Cytl1: its role in chondrogenesis, cartilage homeostasis, and disease
por: Zhu, Sipin, et al.
Publicado: (2019)

Silencing of Eag1 Gene Inhibits Osteosarcoma Proliferation and Migration by Targeting STAT3-VEGF Pathway
por: Wu, Xinyu, et al.
Publicado: (2015)

Multifunctional inorganic biomaterials: New weapons targeting osteosarcoma
por: Wang, Dong, et al.
Publicado: (2023)

Anti-Osteoclast Effect of Exportin-1 Inhibitor Eltanexor on Osteoporosis Depends on Nuclear Accumulation of IκBα–NF-κB p65 Complex
por: Chen, Junchun, et al.
Publicado: (2022)

Construction of a transcription factor-miRNA-mRNA interactive network elucidates underlying pathogenesis for osteosarcoma and validation by qRT-PCR
por: Tang, Fuxing, et al.
Publicado: (2022)

Interleukin-22 Promotes Osteosarcoma Cell Proliferation and Invasion via STAT3 Activation
por: Li, Panpan, et al.
Publicado: (2018)

Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor
por: McCann, Georgia A., et al.
Publicado: (2014)

Serglycin promotes proliferation, migration, and invasion via the JAK/STAT signaling pathway in osteosarcoma
por: Lv, Bin, et al.
Publicado: (2021)

Suppressing STAT5 signaling affects osteosarcoma growth and stemness
por: Subramaniam, Dharmalingam, et al.
Publicado: (2020)

Resveratrol eliminates cancer stem cells of osteosarcoma by STAT3 pathway inhibition
por: Peng, Lihua, et al.
Publicado: (2018)

Inhibition of STAT3 blocks protein synthesis and tumor metastasis in osteosarcoma cells
por: Zuo, Dongqing, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9d3ltk38hn3evl34mpa894fd34